324 related articles for article (PubMed ID: 24020129)
1. Risk factors for Clostridium difficile-associated diarrhea and the effectiveness of prophylactic probiotic therapy.
Mizui T; Teramachi H; Tachi T; Tamura K; Shiga H; Komada N; Umeda M; Koda A; Aoyama S; Goto C; Tsuchiya T
Pharmazie; 2013 Aug; 68(8):706-10. PubMed ID: 24020129
[TBL] [Abstract][Full Text] [Related]
2. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
3. [Clostridium-difficile-associated diarrhea].
Bujanda L; Cosme A
Gastroenterol Hepatol; 2009 Jan; 32(1):48-56. PubMed ID: 19174100
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus.
Asha NJ; Tompkins D; Wilcox MH
J Clin Microbiol; 2006 Aug; 44(8):2785-91. PubMed ID: 16891493
[TBL] [Abstract][Full Text] [Related]
5. The role of probiotics in the prevention and treatment of antibiotic-associated diarrhea and Clostridium difficile colitis.
Friedman G
Gastroenterol Clin North Am; 2012 Dec; 41(4):763-79. PubMed ID: 23101686
[TBL] [Abstract][Full Text] [Related]
6. The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea.
Rohde CL; Bartolini V; Jones N
Nutr Clin Pract; 2009; 24(1):33-40. PubMed ID: 19244146
[TBL] [Abstract][Full Text] [Related]
7. The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea.
Parkes GC; Sanderson JD; Whelan K
Lancet Infect Dis; 2009 Apr; 9(4):237-44. PubMed ID: 19324296
[TBL] [Abstract][Full Text] [Related]
8. [Diarrhea associated with Clostridium difficile. One-year retrospective study at a tertiary hospital].
Barreiro PM; Pintor E; Rosario Burón M; Díaz B; Valverde J; de la Torre F
Enferm Infecc Microbiol Clin; 1998 Oct; 16(8):359-63. PubMed ID: 9835150
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
Kim YG; Graham DY; Jang BI
J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile infection and proton pump inhibitors.
Pohl JF
Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
[TBL] [Abstract][Full Text] [Related]
11. The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers.
Sadeghifard N; Salari MH; Ghassemi MR; Eshraghi S; Amin Harati F
Acta Med Iran; 2010; 48(5):320-5. PubMed ID: 21287466
[TBL] [Abstract][Full Text] [Related]
12. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial.
Hickson M; D'Souza AL; Muthu N; Rogers TR; Want S; Rajkumar C; Bulpitt CJ
BMJ; 2007 Jul; 335(7610):80. PubMed ID: 17604300
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial diarrhea and Clostridium Difficile associated diarrhea in a Turkish University Hospital.
Ergen EK; Akalin H; Yilmaz E; Sinirtaş M; Alver O; Heper Y; Ozakin C; Bakker D; Ener B; Mistik R; Helvaci S; Kuijper EJ
Med Mal Infect; 2009 Jun; 39(6):382-7. PubMed ID: 19269761
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of adverse events and Clostridium difficile-associated diarrhea during long-term antibiotic therapy for osteoarticular infections.
Schindler M; Bernard L; Belaieff W; Gamulin A; Racloz G; Emonet S; Lew D; Hoffmeyer P; Uçkay I
J Infect; 2013 Nov; 67(5):433-8. PubMed ID: 23850617
[TBL] [Abstract][Full Text] [Related]
16. Role of probiotics in antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, and recurrent Clostridium difficile-associated diarrhea.
Surawicz CM
J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S64-70. PubMed ID: 18545161
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
[TBL] [Abstract][Full Text] [Related]
18. Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation.
Vesta KS; Wells PG; Gentry CA; Stipek WJ
Am J Infect Control; 2005 Oct; 33(8):469-72. PubMed ID: 16216661
[TBL] [Abstract][Full Text] [Related]
19. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.
Dial S; Alrasadi K; Manoukian C; Huang A; Menzies D
CMAJ; 2004 Jul; 171(1):33-8. PubMed ID: 15238493
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiology of Clostridium difficile infection].
Szczesny A; Martirosian G
Przegl Epidemiol; 2002; 56(1):49-56. PubMed ID: 12150067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
